TrialAntimicrobial agents and chemotherapy2019

A First-in-Human Trial of GLS4, a Novel Inhibitor of Hepatitis B Virus Capsid Assembly, following Single- and Multiple-Ascending-Oral-Dose Studies with or without Ritonavir in Healthy Adult Volunteers.

Nan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.